Whenever a new virus emerges—be it HIV or SARS-CoV-2—a few lucky people put up a potent natural defense. Monoclonal antibody drugs let them share the health.

Prioritize people who are immunocompromised for early vaccination.

If we could watch what’s really going on in hospitals, there would be no more complacency.

Official guidance seems handed down from on high, rather than based on studies. That will make it harder to beat Covid-19.

Hospitalizations for the disease are at their peak, but the death rate is way down. The simple procedure of flipping people over may be an important reason why.

Some of the leading candidates might work better for the richest people in the world, simply on account of how they’re made.

Amodiaquine, a related treatment for malaria, can beat back Covid-19 in hamsters. But if this drug, too, gets overhyped, there will be awful consequences.

How did an African green monkey that died in 1962 get involved in the biggest research debacle of this pandemic?

Scholars have long warned that constant polling is bad for democracy. In a pandemic, it’s also bad for public health.

We hoped that Covid-19 would be a seasonal infection. We hoped wrong.